BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30133953)

  • 1. The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts.
    Haas M
    Am J Transplant; 2018 Dec; 18(12):2849-2856. PubMed ID: 30133953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of C4d deposition in antibody-mediated rejection.
    Takeda A; Otsuka Y; Horike K; Inaguma D; Hiramitsu T; Yamamoto T; Nanmoku K; Goto N; Watarai Y; Uchida K; Morozumi K; Kobayashi T
    Clin Transplant; 2012 Jul; 26 Suppl 24():43-8. PubMed ID: 22747475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Organ Transplant; 2014 Jun; 19(3):315-22. PubMed ID: 24811440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Revised (2013) Banff Classification for Antibody-Mediated Rejection of Renal Allografts: Update, Difficulties, and Future Considerations.
    Haas M
    Am J Transplant; 2016 May; 16(5):1352-7. PubMed ID: 26696524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological picture of antibody-mediated rejection without donor-specific anti-HLA antibodies: Clinical presentation and implications for outcome.
    Senev A; Coemans M; Lerut E; Van Sandt V; Daniëls L; Kuypers D; Sprangers B; Emonds MP; Naesens M
    Am J Transplant; 2019 Mar; 19(3):763-780. PubMed ID: 30107078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):137-143. PubMed ID: 29300203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes.
    Adam BA; Smith RN; Rosales IA; Matsunami M; Afzali B; Oura T; Cosimi AB; Kawai T; Colvin RB; Mengel M
    Am J Transplant; 2017 Nov; 17(11):2841-2850. PubMed ID: 28444814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Probabilistic Approach to Histologic Diagnosis of Antibody-Mediated Rejection in Kidney Transplant Biopsies.
    Halloran PF; Famulski KS; Chang J
    Am J Transplant; 2017 Jan; 17(1):129-139. PubMed ID: 27340822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvascular inflammation in early protocol biopsies of renal allografts in cases of chronic active antibody-mediated rejection.
    Tsuji T; Yanai M; Itami H; Ishii Y; Akimoto M; Fukuzawa N; Harada H; Fukasawa Y
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():26-30. PubMed ID: 26031582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of monitoring circulating donor-reactive memory B cells to characterize antibody-mediated rejection after kidney transplantation.
    Luque S; Lúcia M; Melilli E; Lefaucheur C; Crespo M; Loupy A; Bernal-Casas D; Gomà M; Jarque M; Crespo E; Montero N; Manonelles A; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
    Am J Transplant; 2019 Feb; 19(2):368-380. PubMed ID: 30085394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial.
    Eskandary F; Jilma B; Mühlbacher J; Wahrmann M; Regele H; Kozakowski N; Firbas C; Panicker S; Parry GC; Gilbert JC; Halloran PF; Böhmig GA
    Am J Transplant; 2018 Apr; 18(4):916-926. PubMed ID: 28980446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.
    Loupy A; Haas M; Solez K; Racusen L; Glotz D; Seron D; Nankivell BJ; Colvin RB; Afrouzian M; Akalin E; Alachkar N; Bagnasco S; Becker JU; Cornell L; Drachenberg C; Dragun D; de Kort H; Gibson IW; Kraus ES; Lefaucheur C; Legendre C; Liapis H; Muthukumar T; Nickeleit V; Orandi B; Park W; Rabant M; Randhawa P; Reed EF; Roufosse C; Seshan SV; Sis B; Singh HK; Schinstock C; Tambur A; Zeevi A; Mengel M
    Am J Transplant; 2017 Jan; 17(1):28-41. PubMed ID: 27862883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
    Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
    Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Banff 2013 update: Pearls and pitfalls in transplant renal pathology.
    Hara S
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():2-8. PubMed ID: 26031578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
    Haas M; Sis B; Racusen LC; Solez K; Glotz D; Colvin RB; Castro MC; David DS; David-Neto E; Bagnasco SM; Cendales LC; Cornell LD; Demetris AJ; Drachenberg CB; Farver CF; Farris AB; Gibson IW; Kraus E; Liapis H; Loupy A; Nickeleit V; Randhawa P; Rodriguez ER; Rush D; Smith RN; Tan CD; Wallace WD; Mengel M;
    Am J Transplant; 2014 Feb; 14(2):272-83. PubMed ID: 24472190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-Mediated Rejection Due to Preexisting versus
    Aubert O; Loupy A; Hidalgo L; Duong van Huyen JP; Higgins S; Viglietti D; Jouven X; Glotz D; Legendre C; Lefaucheur C; Halloran PF
    J Am Soc Nephrol; 2017 Jun; 28(6):1912-1923. PubMed ID: 28255002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated rejection in pediatric small bowel transplantation: Capillaritis is a major determinant of C4d positivity in intestinal transplant biopsies.
    Rabant M; Racapé M; Petit LM; Taupin JL; Aubert O; Bruneau J; Barbet P; Goulet O; Chardot C; Suberbielle C; Lacaille F; Canioni D; Duong Van Huyen JP
    Am J Transplant; 2018 Sep; 18(9):2250-2260. PubMed ID: 29397036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.